Chilivis Grubman Dalbey & Warner
  • Home
  • Firm Overview
  • Attorneys
    • Scott R. Grubman
    • John D. “Randy” Dalbey
    • Lauren A. Warner
    • Jeremy T. Berry
    • Brittany M. Cambre
    • Christian P. Dennis
    • Andrew D. Mason
  • Practice Areas
    • Healthcare
      • Administrative Healthcare
      • Healthcare Audits And Audit Appeals
      • Healthcare Compliance And Audits
      • Healthcare Fraud
      • Healthcare Regulatory Compliance
      • HIPAA
    • White Collar Crime
      • Bank Fraud
      • Grand Jury Investigation
      • Healthcare Fraud
      • Public Corruption
      • Federal Sentencing Issues
      • Internal Investigations
    • Complex Civil Litigation
      • False Claims Act Defense
      • Product Liability
      • Toxic Torts
    • Business Litigation
      • Contracts
    • Professional Misconduct
    • State Bar of Georgia Investigation
    • Data and Cyber Security
    • Government and Public Policy
      • Advocacy and Regulatory Affairs
      • Government Contracts
      • Government Litigation and Administrative Law
    • Campaign Finance and Election Law
  • Blog
  • News
  • Insights
  • Contact
Select Page

Face Mask Mark-Up of $2.50 Leads to Federal Charges

Aug 10, 2020 | Government Investigations, White Collar Crime

On August 6, 2020, the United States Attorney’s Office for the Northern District of Georgia announced that it had charged a Georgia businessman with “hoarding and price gouging” in violation of the Defense Production Act of 1950 (DPA).   According to the government’s...

HHS-OIG Issues Guidance On The Provision Of Free Covid-19 Antibody Testing By Clinical Laboratory

Aug 6, 2020 | COVID-19 Related Law, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid

On August 4, 2020, the Office of Inspector General for the United States Department of Health and Human Services (OIG) updated its FAQs regarding the application of OIG’s administrative enforcement authorities to arrangements directly connected to the ongoing COVID-19...

Senator Grassley Proposes Legislation To Strengthen False Claims Act

Aug 4, 2020 | False Claims Act, Government Investigations

On July 30, 2020, United States Senator Charles Grassley announced that he intends to introduce legislation which would strengthen the federal False Claims Act (FCA).  Grassley indicated that his proposed legislation would, at least in part, specifically address the...

HHS Issues Notice on Reporting Requirements for Provider Relief Fund Recipients

Jul 30, 2020 | COVID-19 Related Law, Government Investigations, Health Care, Medicare and Medicaid

On March 27, 2020, President Trump signed into the law the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”). The CARES Act includes a Provider Relief Fund (“PRF”) with more than $100 billion to reimburse eligible providers for healthcare-related...

Eleventh Circuit Partially Reinstates $348M False Claims Act Jury Verdict

Jul 6, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid

On June 26, 2020, the Eleventh Circuit Court of Appeals reinstated part of a $348 million verdict awarded pursuant to the False Claims Act (FCA). The court also held that a qui tam plaintiff may have standing to bring an FCA claim even after entering into a litigation...

DOJ Announces $729 Million False Claims Act Settlement

Jul 2, 2020 | False Claims Act, Fraud Investigations, Government Investigations, Health Care, Medicare and Medicaid

On July 1, 2020, the U.S. Department of Justice (“DOJ”) announced two separate settlements with Novartis Pharmaceuticals Corporation (“Novartis”), totaling more than $729 million, involving allegations that Novartis paid kickbacks to doctors and patients. In the first...
« Older Entries
Next Entries »

Recent Posts

  • DOJ Releases False Claims Act Statistics for Fiscal Year 2020
  • OCR’s Right of Access Initiative Continues Strong in 2021 with $200K Settlement
  • DOJ Settles FCA Lawsuit Against DME Supplier for $40.5 Million
  • DOJ Announces First Civil Settlement Alleging PPP Fraud
  • Georgia Man That Pled Guilty to Touting Unproven Drugs as COVID-19 Treatment Permanently Barred from Selling Unproven Drugs.

Categories

  • Administrative Law
  • Business Litigation
  • Commercial Litigation
  • COVID-19 Related Law
  • Cyber Law
  • DOJ
  • Election Law
  • Employment Law
  • False Claims Act
  • FINRA
  • Firm Announcement
  • Fraud Investigations
  • General
  • Government Investigations
  • Health Care
  • HIPAA
  • Medicare and Medicaid
  • Non-Profit Organizations
  • Uncategorized
  • White Collar Crime
Built by The Montgomery Group